BackCinCor Pharma Overview

CinCor Pharma Total Current Liabilities

Latest total current liabilities for CINC: $10M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$10.18M
11.81% YoYΔ $-1.36M vs prior year quarter

Peer trimmed avg / median

Loading

CinCor Pharma Total Current Liabilities History

Loading

CinCor Pharma vs. peers: Total Current Liabilities Comparison

Loading

CinCor Pharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CinCor Pharma (CINC) FAQ

CinCor Pharma (CINC) currently reports a total current liabilities of $10M as of September 2022. That compares with $12M in the prior-year period — down 11.8% year over year. Use the charts on this page to explore CinCor Pharma's total current liabilities history and peer comparisons.

CinCor Pharma's total current liabilities decreased from $12M to $10M — a 11.8% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CinCor Pharma reported $10M in total current liabilities as of September 2022. That compares with $12M in the prior-year period — down 11.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CinCor Pharma, and consider following CINC for alerts when major investors trade the stock.